Breaking News

Ricerca Launches Preclinical Assays

Screening assays evaluate cytotoxicity in earliest stages of drug discovery

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ricerca Biosciences introduced two new cellular assay services: Early Safety Screening Cytotoxicity and ImmunoSIGNAL Cytokine Storm Cellular Assay. Early Safety Screening Cytotoxicity is a high-throughput model of cytotoxicity testing that, according to the company, provides a quick and cost-effective option suitable for early in vitro toxicity liability assessment. This assay employs high-resolution cell imaging that allows sensitive detection of cell loss and cell proliferation inhibition. It ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters